Article Details
Retrieved on: 2025-02-28 14:12:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes a trial using IO-108 combined with atezolizumab and bevacizumab for treating hepatocellular carcinoma. This highlights business intelligence in developing advanced therapies, aligning with tags like antibodies, liver cancer, and Roche.
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here